Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression - Wikidata - awgldk - TriplyDB

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

http://www.wikidata.org/entity/Q27485914

about

Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases.Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition.Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uraci Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma.Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization?Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection.Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma.Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma.Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo.Direct biliopancreatoduodenal invasion by hepatocellular carcinoma: report of the first resected case and review of the literature.Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders.Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review).Current status of hepatocellular carcinoma treatment in Japan: hepatic arterial infusion chemotherapy.Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus.Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan.Recent advances in the surgical treatment of hepatocellular carcinoma.Recent advances in liver resection for hepatocellular carcinoma.Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells.Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.Evaluating the current surgical strategies for hepatocellular carcinoma.Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line.Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.Complete pathological response to transcatheter arterial infusion despite a rapidly progressing recurrent hepatocellular carcinoma with portal vein tumor thrombus: A case report.Current chemotherapies for advanced hepatocellular carcinoma.Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.Combined IFN-α and 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombus.Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53

P2860

Q33294127-D19F13C4-8A77-466F-9C2A-F1F60AB86F2E Q33379418-2559DE6A-EADA-487D-9A28-0D6171CD8DA6 Q33400353-DA8AF272-F841-4963-A841-7FC23CE7222A Q33429082-CDE7E9C7-FB1B-43CB-AA34-F54A78458363 Q33482624-FEB53DF6-5E39-409F-995F-FB5816222F1C Q33509884-01ABB5D7-F84B-4746-A6D3-89DC9E346FAB Q33584901-D0663BC8-8B9D-4DA7-A244-BC50634B0FCC Q34225481-B330FEFB-B1E2-43ED-888E-1F96CAEB30C8 Q34553534-BCF27DFB-C99F-46F5-A7BF-E2C79B8CA768 Q34606618-606C8103-8470-4138-BC40-6E3EE083ED1F Q35664243-B7C98115-546E-407E-9F6F-53C5C54B9A6A Q35915311-9897113C-10EA-47E5-A7B4-C79CD76A717A Q36020150-4EC33723-6AAF-4236-851D-BB3E070DD5C2 Q36230740-DCF569BF-0212-4835-A72F-0D35E131063D Q36945072-25DA46BA-1F5F-4BE1-9BE2-799D4A2BBE0A Q37228472-EC731344-2B1E-400F-8FEA-5806FCC871C5 Q37356216-1F8D58E8-203C-443A-932F-526AF10DCE2F Q37685335-FA9DFCA6-A97E-4CB5-9F30-AB7AD406B6FF Q37801874-2A388809-E313-42B7-AB8C-055ABA49398C Q37965882-CB1DA964-1291-4052-BCCD-186B9F28DCFD Q38022245-5805AD8D-D639-452E-80FE-169C6C2E21AC Q38032906-7B427052-33F5-4CBF-BC22-260D1C812ED0 Q38099558-4384D632-EB20-47AF-87EC-F312899A8E53 Q38161384-8BAE1A41-9EEA-40C0-9615-69C721BC6CF2 Q38262115-E12D59DA-61FD-4B5F-AB34-2D554E5A7721 Q38320467-A0560FF5-D91E-4B92-A53A-F2963D38CB83 Q38344688-E1FA3955-F9BB-4D6C-8C7B-945136F73C8F Q38490645-8572CA9B-0E38-4189-8CEB-1BF43763FDCE Q38630530-75C5863A-4B36-4BA3-AA78-361F6D04E98F Q38976484-4D879CD9-5459-47C2-900B-14E90FE6018A Q38982079-EA6CAFE5-6ECE-40E0-BDF5-3A34D1DCF4B0 Q39178798-D80C39BC-3C50-4530-9DDC-A2FF2057D125 Q40614246-5ECEF3C6-1E73-439D-BF9F-227DB00B4C82 Q40729549-5BAD5EF2-A568-4767-A2FF-CF5DF82FF4E4 Q40798040-63083495-53D3-4CE2-9D2C-48F526E885A3 Q41220547-F79CC856-F64D-45D0-A5EC-A0474380BD81 Q41576938-1F3E9F47-6235-4AB3-8086-DF20F8E2275A Q41811162-0B03210D-250D-4E1E-A796-BDF9B12B9D6F Q41992675-0CB48843-D894-44A0-BD17-0B9AAD65C26F Q42154446-26A4C372-9307-4BBB-A7D0-64A1ED8F9453

P2860

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

http://www.wikidata.org/entity/Q27485914

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Treatment of hepatocellular ca ...... interferon receptor expression

@ast

Treatment of hepatocellular ca ...... interferon receptor expression

@en

Treatment of hepatocellular ca ...... interferon receptor expression

@nl

type

label

Treatment of hepatocellular ca ...... interferon receptor expression

@ast

Treatment of hepatocellular ca ...... interferon receptor expression

@en

Treatment of hepatocellular ca ...... interferon receptor expression

@nl

prefLabel

Treatment of hepatocellular ca ...... interferon receptor expression

@ast

Treatment of hepatocellular ca ...... interferon receptor expression

@en

Treatment of hepatocellular ca ...... interferon receptor expression

@nl

P1433

Q27485914-923A64F4-7047-4EE2-AE41-DDB3B76B025B

P1476

Q27485914-F2CFEEA0-02F7-4A27-861F-F1A4ECB9444C

P2093

Q27485914-08716CDE-0578-4F00-8D70-F661E912C7B5

Q27485914-10A6150C-B83C-47F3-ABD4-80042D19CF07

Q27485914-15F00877-76AB-4D12-9426-10E3FD846A1C

Q27485914-183B9AA3-327F-4CE7-A66C-0481B2ABFC9A

Q27485914-3BF8EE59-6CF6-4DFC-868E-A538A1CAD989

Q27485914-4D52B3BA-20C6-4668-909A-C0096801CE7B

Q27485914-610C46CD-47E3-4EA7-A1B6-CC9069A5E653

Q27485914-6124539C-ABBE-4D3F-A138-BC8EF9C4C3CC

Q27485914-63063CDD-3A87-4F66-A059-3BBDBDE4D46C

Q27485914-797004DA-22E6-4F7A-9B5B-AC6C55C70269

P2860

Q27485914-07130848-AB5D-4FEE-89BF-427A2655F837

Q27485914-12C9354D-4C55-4E3D-A37C-C3CB11226B80

Q27485914-1B8A60AE-E053-495D-916C-6A1349A4108B

Q27485914-26381365-7E6B-4226-9764-3F182C55BF86

Q27485914-298773FF-5077-447D-816E-984677856FD4

Q27485914-2A0A0A41-F61E-40B1-9AE7-A1772ED10B01

Q27485914-2D27C491-66B0-428D-B15E-9109131409D8

Q27485914-3114464F-A70F-4227-B5BA-9AA1171F907C

Q27485914-32A8E849-DA58-4490-92C5-DF54DC5209CE

Q27485914-3650CC5E-8231-40B9-B606-965892EBDC67

P2888

Q27485914-C50C74C8-7772-4B10-A701-0F613385B168

P304

Q27485914-3A21F0C2-CE09-430B-9B6B-EB75E8D46200

P31

Q27485914-9709864D-7FB8-4324-86FF-08D6472A3BD6

P356

Q27485914-46D250EE-FF6D-4367-BBCE-C01259AED1B5

P407

Q27485914-9164770A-E637-4F7B-9EF0-C1BB84E829C3

P433

Q27485914-CADE488E-1844-4341-A938-CFFC31E62D08

P478

Q27485914-07C6A57A-7772-45F3-9A9E-5C740CD60914

P577

Q27485914-A21A04E5-AEC9-4600-93B9-A0883B317F77

P5875

Q27485914-6DC62017-209B-47B6-8F33-B1A1D914A566

P6179

Q27485914-1761FB09-DC35-4230-B754-BD38EF881A5E

P698

Q27485914-678B0F9A-6030-4A2E-993B-3346DCC12210

P921

Q27485914-527F864B-956B-4450-8C0D-2CCB17BCF3DB

P932

Q27485914-A84707F7-B37C-4159-A80A-DBB0AF877912

P356

P1433

British Journal of Cancer

P1476

Treatment of hepatocellular ca ...... interferon receptor expression

@en

P2093

A Miyamoto

http://www.w3.org/2001/XMLSchema#string

B Damdinsuren

http://www.w3.org/2001/XMLSchema#string

H Eguchi

http://www.w3.org/2001/XMLSchema#string

H Nagano

http://www.w3.org/2001/XMLSchema#string

H Ota

http://www.w3.org/2001/XMLSchema#string

H Wada

http://www.w3.org/2001/XMLSchema#string

K Dono

http://www.w3.org/2001/XMLSchema#string

K Umeshita

http://www.w3.org/2001/XMLSchema#string

K Wakasa

http://www.w3.org/2001/XMLSchema#string

M Kondo

http://www.w3.org/2001/XMLSchema#string

P2860

The human interferon alpha/beta receptor: characterization and molecular cloning

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.

Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b.

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

Cytokine triggered molecular pathways that control cell cycle arrest.

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

P2888

P304

557-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602742

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7654965

http://www.w3.org/2001/XMLSchema#string

P6179

1016563097

http://www.w3.org/2001/XMLSchema#string

P698

16106266

http://www.w3.org/2001/XMLSchema#string

P921

P932

2361594

http://www.w3.org/2001/XMLSchema#string